Spatially confined photoacoustic effects of responsive nanoassembly boosts lysosomal membrane permeabilization and immunotherapy of triple-negative breast cancer

被引:0
|
作者
Li, Kunlin [1 ]
Li, Lin [1 ]
Xie, Xiyue [1 ]
Zhu, Jing [1 ]
Xia, Daqing [1 ]
Xiang, Lunli [1 ]
Cai, Kaiyong [1 ]
Zhang, Jixi [1 ]
机构
[1] Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, 174 Shazheng St, Chongqing 400044, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor immunotherapy; Responsive self-assembly; Photoacoustic effects; Lysosomal membrane permeabilization; Endoplasmic reticulum stress; THERAPY;
D O I
10.1016/j.actbio.2024.08.021
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Although immunogenic cell death (ICD) induced by lysosomal membrane permeabilization (LMP) evidently enhance the effectiveness of antitumor immunity for triple-negative breast cancer (TNBC) with poor immunogenicity, their potential is increasingly restricted by the development of other death pathways and the repair of lysosomes by endoplasmic reticulum (ER) during LMP induction. Herein, a poly- dopamine nanocomposite with i-motif DNA modified and BNN6 loaded is prepared toward boosting LMP and immunotherapy of TNBC by synergy of spatially confined photoacoustic (PA) effects and nitric oxide. Combining the high-frequency pulsed laser (40 0 0 kHz) with the intra-lysosomal assembly of nanocomposites produced spatially confined and significantly boosted PA effects (4.8-fold higher than the individually dispersed particles extracellular), suppressing damage to other cellular components and selectively reducing lysosomal integrity to 19.2 %. Simultaneously, the releasing of nitric oxide inhibited the repair of lysosomes by ER stress, causing exacerbated LMP. Consequently, efficient immune activation was achieved, including the abundant releasing of CRT/HMGB1 (5.93-6.8-fold), the increasing maturation of dendritic cells (3.41-fold), and the fostered recruitment of CD4+/CD8+ T cells (3.99-3.78-fold) in vivo . The study paves a new avenue for the rational design and synergy of confined energy conversion and responsive nanostructures to achieve the treatment of low immunogenicity tumors.
引用
收藏
页码:381 / 395
页数:15
相关论文
共 50 条
  • [21] Immunotherapy in Triple-Negative Breast Cancer: Present and Future
    Isaac Kim
    Katherine Sanchez
    Heather L. McArthur
    David Page
    Current Breast Cancer Reports, 2019, 11 : 259 - 271
  • [22] Tumor microenvironment and immunotherapy for triple-negative breast cancer
    Guo, Zijie
    Zhu, Ziyu
    Lin, Xixi
    Wang, Shenkangle
    Wen, Yihong
    Wang, Linbo
    Zhi, Lili
    Zhou, Jichun
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [23] The clinical promise of immunotherapy in triple-negative breast cancer
    Vikas, Praveen
    Borcherding, Nicholas
    Zhang, Weizhou
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6823 - 6833
  • [24] Oncolytic Immunotherapy for Treatment of Breast Cancer, Including Triple-Negative Breast Cancer
    Bramante, Simona
    Koski, Anniina
    Liikanen, Ilkka
    Oksanen, Minna
    Joensuu, Timo
    Pesonen, Sari
    Hemminki, Akseli
    MOLECULAR THERAPY, 2015, 23 : S173 - S173
  • [25] Immunotherapy for triple-negative breast cancer-State of the art
    Stickeler, Elmar
    Fehm, Tanja
    GYNAKOLOGIE, 2023, 56 (04): : 239 - 244
  • [26] Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer
    Salatino, Mariana
    Romina Girotti, Maria
    Rabinovich, Gabriel A.
    CANCER CELL, 2018, 33 (02) : 155 - 157
  • [27] Immunotherapy for Early-Stage Triple-Negative Breast Cancer
    Burstein, Harold J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (21): : 2048 - 2049
  • [28] Spatial predictors of immunotherapy response in triple-negative breast cancer
    Wang, Xiao Qian
    Danenberg, Esther
    Huang, Chiun-Sheng
    Egle, Daniel
    Callari, Maurizio
    Bermejo, Begona
    Dugo, Matteo
    Zamagni, Claudio
    Thill, Marc
    Anton, Anton
    Zambelli, Stefania
    Russo, Stefania
    Ciruelos, Eva Maria
    Greil, Richard
    Gyorffy, Balazs
    Semiglazov, Vladimir
    Colleoni, Marco
    Kelly, Catherine M.
    Mariani, Gabriella
    Del Mastro, Lucia
    Biasi, Olivia
    Seitz, Robert S.
    Valagussa, Pinuccia
    Viale, Giuseppe
    Gianni, Luca
    Bianchini, Giampaolo
    Ali, H. Raza
    NATURE, 2023, 621 (7980) : 868 - +
  • [29] Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
    Llinas-Arias, Pere
    Iniguez-Munoz, Sandra
    McCann, Kelly
    Voorwerk, Leonie
    Orozco, Javier I. J.
    Ensenyat-Mendez, Miquel
    Sese, Borja
    DiNome, Maggie L.
    Marzese, Diego M.
    CANCERS, 2021, 13 (16)
  • [30] Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
    Jacobs, Flavia
    Agostinetto, Elisa
    Miggiano, Chiara
    De Sanctis, Rita
    Zambelli, Alberto
    Santoro, Armando
    CANCERS, 2023, 15 (11)